RxDoctor Payments DataLook up a doctor →

Jennifer Loh, MD

Ophthalmology · Miami, FLNPI 1528227691

Payments from drug & device makers

$606,305in general payments, 2019–2025

Across 1,425 payments — averaging $425.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$133K
  • Alcon$115K
  • Sight Sciences, Inc.$104K
  • Sun Pharmaceutical Industries Inc.$58K
  • Kala Pharmaceuticals, Inc.$32K
  • AbbVie$30K
  • plus $135K from 40 others
$25,227in research payments, 2019–2025

Across 4 payments — averaging $6306.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sight Sciences, Inc.$25K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bausch & Lomb Americas Inc.187$132,554
Alcon198$115,301
Sight Sciences, Inc.81$103,792
Sun Pharmaceutical Industries Inc.168$58,077
Kala Pharmaceuticals, Inc.88$31,530
AbbVie(2 entities)142$29,873
Johnson & Johnson Surgical Vision, Inc.45$25,924
Tarsus Pharmaceuticals, Inc.46$12,533
Aerie Pharmaceuticals, Inc.34$12,472
Amgen(2 entities)30$12,294
Alcon Research LLC7$11,788
Carl Zeiss Meditec, Inc.14$11,612
Dompe US, Inc.23$7,733
Beaver-visitec International, Inc.7$5,715
Lensar, Inc.13$4,158
Biotissue Holdings Inc.16$4,078
Nordic Pharma, Inc.1$3,500
Oyster Point Pharma, Inc.68$2,911
Novartis39$2,879
Bausch & Lomb, A Division Of Bausch Health US, LLC22$2,650
Ocular Therapeutix, Inc.4$2,641
Eyevance Pharmaceuticals LLC28$2,517
Thea Pharma Inc.20$1,955
Mallinckrodt Hospital Products Inc.62$1,780
NEW World Medical,inc.18$1,397
Omeros Corporation4$1,257
Carl Zeiss Meditec USA, Inc.7$613
Glaukos Corporation6$609
Rxsight Inc6$413
Harrow Eye, LLC8$367
Mallinckrodt Enterprises LLC10$350
Optos, Inc.3$177
Rayner Intraocular Lenses Limited2$144
Shire North American Group Inc6$129
Regeneron Healthcare Solutions, Inc.1$122
Astellas Pharma US Inc1$122
Carl Zeiss Meditec Cataract Technology Inc.1$103
Optovue, Inc.1$66
Johnson & Johnson Vision Care, Inc.1$38
Halozyme Inc1$26
Santen Inc.1$24
Apellis Pharmaceuticals, Inc.1$20
Carl Zeiss Meditec AG1$19
Quidel Corporation1$17
Merck1$14
Melinta Therapeutics, LLC1$13

How this compares

$606,305 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$142,452
Medicare patients
343
Services billed
989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →